Sandbox:Shakiba: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "__NOTOC__ {{AE}} {{SHA}} == Overview ==")
Tag: Replaced
Line 3: Line 3:


== Overview ==
== Overview ==
[[Esophagitis]] is the inflammation of the esophagus.[https://en.wikipedia.org/wiki/Esophagitis]
== Historical Perspective ==
== Classification ==
* Esophagitis  may be classified into 5 subtypes/groups:<ref name=":0" />
** Reflux esophagitis
**Infectious esophagitis
***Fungal
****[[Candida]]
*** Viral
**** Herpes simplex
**** Cytomegalovirus
** Drug-induced esophagitis
** Eosinophilic esophagitis
** Caustic esophagitis
<br />
{| style="width:60%; height:100px" border="1"
|+
! style="width:25%" bgcolor="LightSteelBlue" ; border="1" | '''A'''
! style="width:25%" bgcolor="LightSteelBlue" ; border="1" | B
|-
|bgcolor="Beige" | 1
|bgcolor="Beige" |2
|-
|bgcolor="Beige" |3
|bgcolor="Beige" |4
|-
|bgcolor="Beige" |5
|bgcolor="Beige" |6
|}
== Pathophysiology ==
<br />
{{family tree/start}}
{{Family tree | | |  A  | | | |A=1 }}
{{Family tree |,|-|-|^|-|-|.| | }}
{{Family tree |B  |~|~|~|  C| | B=2| C=3 }}
{{Family tree | | | | | | | | | }}
{{Family tree | | | | | | | | | }}
{{family tree/end}}
== Clinical Features ==
{{familytree/start}}
{{familytree | | | | | | | | |  A  | | | | | | | | |A=A }}
{{familytree | | | | |,|-|-|-|-|^|-|-|-|-|-|-|.| | | }}
{{familytree | | | |  B  | | | | | | | | | |  C  | B=B | C=C }}
{{familytree | | | | |!| | | | | | | | | |,|-|^|-|.| | |}}
{{familytree | | | |  D  |~|~|~|~|~|~|~|  H  | |  I  | |D=D |H=H| I=I }}
{{familytree | | |,|-|^|-|.| | | | | | | | |,|-|-|^|-|-|.| | | |}}
{{familytree | |  F  | |  G  | | | | | | |  J  | | | |  K  | | | | |F=F| G=G |J=J| K=K }}
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | |  E  | | | | | | E=E}}
{{familytree/end}}
== Differentiating Esophagitis from other Diseases ==
== Epidemiology and Demographics ==
=== Age ===
* Esophagitis is more commonly observed among adults.
=== Gender ===
* Esophagitis  affects men and women equally.
=== Race ===
* There is no racial predilection for esophagitis .
== Risk Factors ==
* Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
== Natural History, Complications and Prognosis ==
*Prognosis is generally good.
*If left untreated, [#%] of patients with esophagitis may progress to develop scarring in the esophagus.
*Common complications of esophagitis include esophageal ulcers, Barrett's esophagus, and esophageal cancer.
== Diagnosis ==
=== Diagnostic Criteria ===
=== Symptoms ===
* Symptoms of esophagitis may include the following:
** Epigastric pain
** Nausea or vomitting
** Dysphagia
** Cough
=== Physical Examination ===
=== Laboratory Findings ===
=== Imaging Findings ===
=== Other Diagnostic Studies ===
== Treatment ==
=== Medical Therapy ===
=== Surgery ===
=== Prevention ===
* Effective measures for the primary prevention of esophagitis include finding the cause, life style modifications like avoiding caffeine, alcohol, smoking and fatty food, and drinking fluids when taking medical drugs. cjffjfj. <ref name="pmid19032997">{{cite journal| author=Gibson CM, Pride YB, Frederick PD, Pollack CV, Canto JG, Tiefenbrunn AJ | display-authors=etal| title=Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. | journal=Am Heart J | year= 2008 | volume= 156 | issue= 6 | pages= 1035-44 | pmid=19032997 | doi=10.1016/j.ahj.2008.07.029 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19032997  }} </ref>
== References ==
{{Reflist|2}}
== Table ==
{| border="1" cellpadding="2"
!width="50"|A
!width="225"|B
!width="225"|C
|-
|D|| E || F
|-
|G || H || I
|}
== Column ==
<br />
{{col-begin}}
{{col-break}}
A
B
{{col-break}}
1
2
3
{{col-break}}
X
Y
|}

Revision as of 16:17, 28 June 2020

Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[1]

Overview